BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahiman N, Markina YV, Kesharwani P, Johnston TP, Sahebkar A. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases. J Control Release 2022;348:264-86. [PMID: 35649486 DOI: 10.1016/j.jconrel.2022.05.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohajeri S, Moayedi S, Mohajeri S, Yadegar A, Haririan I. Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1045575] [Reference Citation Analysis]
2 Hu Y, Zhang S, Wen Z, Fu H, Hu J, Ye X, Kang L, Li X, Yang X. Oral delivery of curcumin via multi-bioresponsive polyvinyl alcohol and guar gum based double-membrane microgels for ulcerative colitis therapy. Int J Biol Macromol 2022;221:806-20. [PMID: 36099999 DOI: 10.1016/j.ijbiomac.2022.09.050] [Reference Citation Analysis]
3 Singh V, Sheikh A, Abourehab MAS, Kesharwani P. Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment. Biosensors (Basel) 2022;12:617. [PMID: 36005013 DOI: 10.3390/bios12080617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]